Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma

Fig. 1

MCM6 mRNA expression in 31 clinical samples. (A) The histogram shows the relative expression level of MCM6 mRNA for each sample. (B) The samples are divided into 3 categories according to Shimada pathology classification. The mRNA expression of MCM6 in neuroblastoma is significantly higher than that of ganglioeuroblastoma and ganglioneuroma. The value is displayed as the mean ± SEM and statistical significance is expressed as **** p < 0.0001. NB, neurobastoma; GNB, ganglioeuroblastoma; GN, ganglioneuroma

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us